America’s best management consulting firms 2021

Accenture receives 5 stars from Forbes.

COVID-19: What to do now, what to do next

Accenture surveyed 720 healthcare providers (HCPs) globally on how operations and needs changed during COVID-19 and the effects for patients and pharmas.

Image Thumbnail

Navigating the impact of covid-19

Is COVID-19 altering how pharma engages with HCPs?
Read More

Navigating the impact of COVID-19

Image Thumbnail

Driving digital in biopharma [podcast series]

Experts discuss biopharma’s digital transformation
Read More

Pivot to the patient

Life sciences is evolving rapidly from selling products to delivering value through better patient outcomes.

We work with our pharmaceutical, biotech, medical technology, distributor and consumer health clients globally to redefine the future of the life sciences industry: combining the latest technology with scientific breakthroughs to revolutionize how medical treatments are discovered, developed and delivered to patients around the world.

New science: Biopharma’s new growth engine

Biopharma is facing compressive disruption that could impact traditional approaches. Find out how New Science can reshape the biopharma landscape and deliver better patient outcomes.


New science | Pharma's new growth machine

Accenture's video shows how New Science can reshape the biopharma landscape and patient care to overcome compressive disruption. See more.

View Transcript

Case studies

Public-private partnership model transforms primary care for Kenya’s citizens.

Bristol Myers Squibb upgrades global SAP to S/4HANA in the AWS cloud flawlessly and without business disruption.

Accenture supports forces with Siemens Healthineers in digitizing its customer service processes.

View All

What we think

Awards & recognition

Our Life Sciences solutions are helping businesses deliver exceptional patient experiences. Discover how our awards distinguish us as an industry leader.

View All

Meet Sandra Horning

We are proud to collaborate with leading women in Life Sciences in their quest to advance science and patient care.

Accenture’s Global Life Sciences Lead, Stuart Henderson, speaks to industry icon and inspiration, Sandra Horning.

With more than 30 years in the field, Dr. Sandra Horning is currently the co-founder and board member of EQRx and serves on the board of directors of Gilead Sciences, Moderna and Olema Oncology. Previously she served as executive vice president, chief medical officer and head of global product development for Roche/Genentech. She is a passionate advocate for women in leadership. Read about her inspiring experiences and perspective.


Meet Sandra Horning, MD.

Our leaders

Life Sciences blog

Life Sciences consultants weigh in on how pharma, biotech, medtech and consumer health companies can improve patient outcomes.

Time for a cell & gene bottleneck shift

Accenture reveals the accelerated development in gene therapies is causing a fundamental shift in the traditional biopharmaceutical business model.

APAC MedTech: cybersecurity standards in one place

Accenture's Debmalya Chatterjee shares the key things we have learned while working on a cybersecurity standards database in AsiaPac.

Biopharma’s Journey: Lessons learned from leaders

Explore the seven tenets of data transformation and lessons learned from leaders in biopharma.

Our events

Knowledge of trends and insights are important to Accenture. Join our live thought leader-hosted events and watch on-demand sessions.


Accenture named a leader in Everest group’s Veeva PEAK services matrix assessment 2021

Accenture is named a leader for its market impact, vision, and capabilities in the Everest Group’s Veeva PEAK Services Matrix® Assessment 2021 report.

Medable named Life Sciences Innovation Champion

Medable was named Accenture HealthTech Innovation Challenge – Life Sciences Innovation Champion, providing an integrated clinical trial patient experience.

Takeda accelerates digital transformation with Accenture and AWS

Collaboration will leverage cloud and data-driven insights to accelerate drug development, increase operational agility, reduce technology costs and develop the workforce of the future.

Subscription Center
Stay in the Know with Our Newsletter Stay in the Know with Our Newsletter